Journal profile · ONCOLOGY
Indian Journal of Cancer
ISSN 0019-509X · eISSN 1998-4774 · Wolters Kluwer Medknow Publications · INDIA
Indian Journal of Cancer: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.72; JCR Q4 (journal website); fully open access; median 323 days to acceptance (36 articles, last 24 months); community-reported acceptance: easy; 91 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Indian Journal of Cancer is published by Wolters Kluwer Medknow Publications and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Head and Neck Cancer Studies, Breast Cancer Treatment Studies and Lung Cancer Treatments and Mutations, together about 22.7% of its articles. Its main subfields are Pulmonary and Respiratory Medicine and Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Indian Journal of Cancer (ISSN 0019-509X), the show window of the progress of ontological sciences in India, was established in 1963. Indian Journal of Cancer is the first and only periodical serving the needs of all the specialties of oncology in India.
Source: LetPub
Research area (LetPub): ONCOLOGY
Editor-in-chief Vinay H DeshmanePublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Head and Neck Cancer StudiesMedicine10.3%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology6.3%
- Lung Cancer Treatments and MutationsMedicine6%
- Lung Cancer Diagnosis and TreatmentMedicine5.4%
- Sarcoma Diagnosis and TreatmentMedicine5.1%
- Oral Health Pathology and TreatmentDentistry4.8%
- Global Cancer Incidence and ScreeningMedicine4.5%
- Cancer Diagnosis and TreatmentMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q4 · ONCOLOGY · rank 307/333
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.72LetPub ·
- Impact factor (publisher)
- 0.8Publisher website ·
- CiteScore 2026-06
- 1.5LetPub ·
- SJR 2026-06
- 0.31LetPub ·
- SNIP 2026-06
- 0.43LetPub ·
- h-index
- 29LetPub ·
- h-index
- 63OpenAlex ·
- i10-index
- 809OpenAlex ·
- 2-year mean citedness
- 0.75OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 66.56%LetPub ·
Volume
- Articles per year
- 85LetPub ·
Articles by year OpenAlex count · 2,501 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 22 | 11 | 0 |
| 2025 | 91 | 91 | 38 |
| 2024 | 107 | 95 | 128 |
| 2023 | 84 | 42 | 224 |
| 2022 | 129 | 55 | 648 |
| 2021 | 134 | 26 | 569 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
323 daysMedian, submission to acceptance · P25–P75 92 days – 739 days
- Acceptance to online
- median 66 days (36 articles)
- Submission to online
- median 490 days
- Sample
- 36 articles with submission and acceptance dates (145 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Medknow Publications
- Country or region
- INDIA
- Language
- English
- ISSN
- 0019-509X
- Electronic ISSN
- 1998-4774
- Latest issue on the website
- Volume 63, Issue 1 (March 2026)
- Official links
- Journal homepage ↗LetPub
FAQ
Frequently asked questions about Indian Journal of Cancer
What CAS zone is Indian Journal of Cancer in?
In the 2025 upgraded edition of the CAS Journal Ranking, Indian Journal of Cancer is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Indian Journal of Cancer?
The latest impact factor listed by LetPub is 0.72; CiteScore 1.5, h-index 63.
How long does peer review take at Indian Journal of Cancer?
Based on the dates recorded on 36 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 323 days (interquartile range 92–739 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Indian Journal of Cancer in?
The journal's website gives JCR Q4; by category, ONCOLOGY Q4 (307/333). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index Indian Journal of Cancer?
According to LetPub and DOAJ records, Indian Journal of Cancer is indexed in SCIE and Scopus.
Is Indian Journal of Cancer open access, and what is the APC?
Indian Journal of Cancer is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .